Department of Neurosurgery, Second Affiliated Hospital, School of medicine, Zhejiang University, Hangzhou, 310000, China.
Biomed Pharmacother. 2021 May;137:111416. doi: 10.1016/j.biopha.2021.111416. Epub 2021 Feb 24.
RNA modification is an important form of regulation in cancer biology, that is capable of affecting cell proliferation, migration, other genetic characteristics of tumors, and protein expression. Recent research has shown that dysregulation of RNA modification plays an important role in glioma pathogenesis. A key form of RNA post-transcriptional modification, alternative polyadenylation (APA), may represent a mechanism by which genes escape miRNA-mediated inhibition of cancer. Global shortening of 3' untranslated region (3'-UTR)-mediated APA events have become a potential novel marker of cancer progression. Current treatments in which a single gene or pathway is targeted do not have significant therapeutic benefits for glioma patients, while strategies that are less targeted, in which inhibitors of major regulatory hubs such as APA regulators are utilized, may have superior therapeutic effects. However, the precise mechanisms by which untranslated region-alternative polyadenylation (UTR-APA) regulates glioma are poorly understood. In the present review, we will discuss the important roles of UTR-APA in glioma. In addition to the role of APA in the progression of glioma, we will also explore potential treatment options that target these processes to improve the prognosis of glioma patients.
RNA 修饰是癌症生物学中一种重要的调控形式,能够影响细胞增殖、迁移和肿瘤的其他遗传特征以及蛋白质表达。最近的研究表明,RNA 修饰的失调在神经胶质瘤的发病机制中起着重要作用。RNA 转录后修饰的一种关键形式,可变多聚腺苷酸化(APA),可能代表了基因逃避 miRNA 抑制癌症的一种机制。3'非翻译区(3'-UTR)介导的 APA 事件的全局缩短已成为癌症进展的潜在新型标志物。目前针对单个基因或途径的治疗方法对神经胶质瘤患者没有显著的治疗益处,而靶向性较低的策略,即利用 APA 调节剂等主要调控枢纽的抑制剂,可能具有更好的治疗效果。然而,UTR-APA 调节神经胶质瘤的确切机制还知之甚少。在本综述中,我们将讨论 UTR-APA 在神经胶质瘤中的重要作用。除了 APA 在神经胶质瘤进展中的作用外,我们还将探讨针对这些过程的潜在治疗选择,以改善神经胶质瘤患者的预后。